Huadong Medicine Co Stock Gross Profit
| 000963 Stock | 41.45 0.29 0.70% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Huadong Medicine's long-term financial health and intrinsic value.
Huadong |
Huadong Medicine Co Company Gross Profit Analysis
Huadong Medicine's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Huadong Medicine Gross Profit | 14.6 B |
Most of Huadong Medicine's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Huadong Medicine Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Huadong Medicine Co reported 14.6 B of gross profit. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The gross profit for all China stocks is notably lower than that of the firm.
Huadong Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Huadong Medicine's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Huadong Medicine could also be used in its relative valuation, which is a method of valuing Huadong Medicine by comparing valuation metrics of similar companies.Huadong Medicine is currently under evaluation in gross profit category among its peers.
Huadong Fundamentals
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0724 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 70.61 B | ||||
| Shares Outstanding | 1.75 B | ||||
| Shares Owned By Insiders | 58.14 % | ||||
| Shares Owned By Institutions | 13.41 % | ||||
| Price To Book | 3.01 X | ||||
| Price To Sales | 1.69 X | ||||
| Revenue | 41.91 B | ||||
| Gross Profit | 14.6 B | ||||
| EBITDA | 5.09 B | ||||
| Net Income | 3.51 B | ||||
| Total Debt | 2.4 B | ||||
| Book Value Per Share | 13.95 X | ||||
| Cash Flow From Operations | 3.75 B | ||||
| Earnings Per Share | 2.11 X | ||||
| Target Price | 49.75 | ||||
| Number Of Employees | 18.27 K | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 72.7 B | ||||
| Total Asset | 37.88 B | ||||
| Retained Earnings | 17.46 B | ||||
| Working Capital | 7.26 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 37.88 B | ||||
| Last Dividend Paid | 0.93 |
About Huadong Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Huadong Medicine Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Huadong Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Huadong Medicine Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price |
Other Information on Investing in Huadong Stock
Huadong Medicine financial ratios help investors to determine whether Huadong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Huadong with respect to the benefits of owning Huadong Medicine security.